BROOKE GARCIA: Open Payments
NPI 1518268549 · MILILANI, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150,183 in 690 payments from 21 companies in 2025. Trend: 2023 $68,805 · 2024 $105,093 · 2025 $150,183
Speaker / faculty: $91,428Consulting: $23,771Travel & lodging: $17,226Food & beverage: $14,158Speaker / faculty: $3,240Education: $359
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 107 | $31,838 |
| Arcutis Biotherapeutics, Inc. | 104 | $27,616 |
| Regeneron Healthcare Solutions, Inc. | 63 | $23,878 |
| ABBVIE INC. | 75 | $12,666 |
| GENZYME CORPORATION | 40 | $11,772 |
| Galderma Laboratories, L.P. | 50 | $10,318 |
| PFIZER INC. | 31 | $10,248 |
| Incyte Corporation | 58 | $9,743 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 28 | $4,991 |
| Kowa Pharmaceuticals America, Inc. | 4 | $2,110 |
Products named: DUPIXENT, ZORYVE, CIBINQO, OPZELURA, EBGLYSS, NEMLUVIO, RINVOQ, ILUMYA.
Industry payments across HI — which companies pay providers there.
